Skip to main contentSkip to footer
finger pointing scan
Brighton & Sussex Medical School

Staff Profiles

BSMS > About BSMS > Contact us > Staff > Dr Valerie Jenkins

Dr Valerie Jenkins

Val Jenkins web

Dr Valerie Jenkins (DPhil, BSc)

Senior Research Fellow
T: +44 (0)1273 873016
Location: Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Room 2, University of Sussex, Brighton, BN1 9RX

DA: Mrs Tracy Woodcock
T: +44 (0)1273 873019

Areas of expertise: Psycho-oncology; neuropsychological impairments associated with cancer treatments; patient reported outcomes; production of communication skills training materials; yoga

Research areas: Active collaborations with health care professionals working in oncology locally and across the UK


Dr Valerie Jenkins originally trained as a nurse in Wales and worked in oncology before completing her BSc in Experimental Psychology (1989) and Doctorate in Neuropsychology (1996) at the University of Sussex. 


Valerie's eclectic range of work experiences and research interests have culminated in the development of relevant, evidence-based educational initiatives for the benefit of healthcare professionals and their patients. Her research interests are wide, and include the impact of chemotherapy and endocrine therapies on cognition, intervention studies examining the effect of complementary therapies (including acupuncture, yoga and hypnosis) to alleviate side effects from cancer treatments, and also assessing quality of life in patients undergoing treatment trials.

Please visit the relevant sections of the SHORE-C website

Selected publications

Jenkins V, Fallowfield L, Langridge C, Barrett J, Ryan A, Jacobs I et al. Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening. International Journal of Gynecological Cancer. 2015;25(8):1519-1525.

Harder H, Langridge C, Solis-Trapala I, Zammit C, Grant M, Rees D et al. Post-operative exercises after breast cancer surgery: Results of a RCT evaluating standard care versus standard care plus additional yoga exercise. European Journal of Integrative Medicine. 2015;7(3):202-210.

Jenkins V, Catt S, Banerjee S, Gourley C, Montes A, Solis-Trapala I et al. Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study. Br J Cancer. 2013;108(11):2264-2271.

Fallowfield L, Solis-Trapala I, Jenkins V. Evaluation of an Educational Program to Improve Communication with Patients About Early-Phase Trial Participation. The Oncologist. 2012;17(3):377-383.

Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot D, Fallowfield L. What Oncologists Believe They Said and What Patients Believe They Heard: An Analysis of Phase I Trial Discussions. Journal of Clinical Oncology. 2010;29(1):61-68.

Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C et al. The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer. 2010;103(12):1801-1807.

Jenkins V, Ambroisine L, Atkins L, Cuzick J, Howell A, Fallowfield L. Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). The Lancet Oncology. 2008;9(10):953-961.

Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94(6):828-834.

Jenkins V, Fallowfield L, Edginton T, Payne H, Hamilton E. Preferences of hxealthy men for two different endocrine treatment options offered for locally advanced prostate cancer. Current Medical Research and Opinion. 2005;21(9):1329-1335.

Jenkins V. Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ. 2005;330(7488):400-0.

A full list of publications is available on request or can be viewed on the SHORE-C website